| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000004184 |
| Receipt No. | R000005028 |
| Official scientific title of the study | Prospective Study of Hypofractionated Partial Breast Irradiation using 3D-Conformal Radiotherapy |
| Date of disclosure of the study information | 2010/09/13 |
| Last modified on | 2016/12/26 (Ver. 10) |
| Basic information | ||
| Official scientific title of the study | Prospective Study of Hypofractionated Partial Breast Irradiation using 3D-Conformal Radiotherapy | |
| Title of the study (Brief title) | 3D-HPBI Trial | |
| Region |
|
|
| Condition | |||
| Condition | Breast cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the safe and effectiveness of partial breast irradiation (30 Gy/5 fraction) for early breast cancer |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase II |
| Assessment | |
| Primary outcomes | 2-year late adverse events |
| Key secondary outcomes | overall survival, disease-free survival, local recurrence-free survival, compliance for treatment, acute adverse events, cosmesis |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Radiotherapy (Photon and/or electron)
30Gy/5fractions/2wks |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Stage 1
partial breast resection axillary resection or sentinel lumph node biopsy were performed invasive ductal carcinoma less than 5.5 cm of the distance clip PS0-1 no privious radiotherapy informed consent |
|||
| Key exclusion criteria | active double cancer
active infection pregnancy mental disorder collagen disease |
|||
| Target sample size | 55 | |||
| Research contact person | |
| Name of lead principal investigator | Yoshikazu Kagami |
| Organization | Showa University, School of Medicine |
| Division name | Radiation Oncology |
| Address | Hatanodai 1-5-8, Hinagawa-ku, 142-8555 Tokyo Japan |
| TEL | 03-6426-3228 |
| kagami@med.showa-u.ac.jp | |
| Public contact | |
| Name of contact person | Naoto Shikama |
| Organization | Saitama Medical University International Hospital |
| Division name | Radiation Oncology |
| Address | 1397-1 Yamane Hidakashi, 350-1298, Japan |
| TEL | 042-984-4111 |
| Homepage URL | |
| nshikama0525@gmail.com | |
| Sponsor | |
| Institute | Health and Labor Sciences Research Grants (H21-018) |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Health and Labor Sciences Research Grants (H21-018) |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 佐久総合病院(長野県)、埼玉医科大学国際医療センター(埼玉県)、聖路加国際病院(東京都)、都立駒込病院(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | https://www.ncbi.nlm.nih.gov/pubmed/27127160 |
| Results | Fifty-three patients were treated using photons in the supine position, and two patients received photon and electron beams. Three patients (5%) developed grade 2 symptomatic radiation pneumonitis at 5, 8, and 9 months after 3D-CRT APBI.
ILV10Gy should be lower than 10% to avoid symptomatic radiation pneumonitis after 3D-CRT APBI. |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000005028 |